Dr Reddys Laboratories
informed the exchanges regarding the audit of its API manufacturing plant 2 at Bollaram, Hyderabad
The company said that it has received the Establishment Inspection Report (EIR) from USFDA, for the above-referred facility, indicating closure of the audit and the inspection classification of this facility is determined as Voluntary Action Initiated (VAI).
Dr Reddys Laboratories Ltd is currently trading at Rs2,627.80 up by Rs15.25 or 0.58% from its previous closing of Rs2,612.55 on the BSE.
The scrip opened at Rs2,635 and has touched a high and low of Rs2,666.55 and Rs2,600.10 respectively. So far 2,38,416 (NSE+BSE) shares were traded on the counter. pp
The current market cap of the company is Rs43,406.41cr.